Osborne Clarke advises syndicate of investors led by Gilde Healthcare and Versant Ventures on EUR 16 million financing round of Lava Therapeutics
International legal practice Osborne Clarke advises a syndicate of investors led by Gilde Healthcare and Versant Ventures with additional support...
Published on
24/05/2018
Read time
1m